CCM
TSVT

CAAS Capital Management’s 2seventy bio TSVT Stock Holding History

CAAS Capital Management’s Portfolio TSVT Stock Details TSVT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-14,383
Closed -$147K – 854
2023
Q1 		$147K Buy
+14,383
New +$164K 0.01% 593
2022
Q4 		– Sell
-228,245
Closed -$3.32M – 965
2022
Q3 		$3.32M Sell
228,245
-470,891
-67% -$6.99M 0.16% 196
2022
Q2 		$9.23M Buy
699,136
+553,171
+379% +$7.54M 0.46% 49
2022
Q1 		$2.49M Sell
145,965
-56,153
-28% -$953K 0.1% 203
2021
Q4 		$5.18M Buy
+202,118
New +$6.3M 0.13% 180

Other funds holding TSVT

KCM
Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

CAAS Capital Management's TSVT Position: Q2 2023 in Review

CAAS Capital Management sold out of 2seventy bio (TSVT) in Q2 2023, closing a stake of 14,383 shares — an estimated $147K sold.

CAAS Capital Management first reported a position in TSVT in Q4 2021 and held it in 5 quarters. The position peaked at $9.23M in Q2 2022. 149 funds tracked by Wall St. Rank hold TSVT as of Q2 2023.

  • CAAS Capital Management reported no remaining 2seventy bio position as of Q2 2023 after selling out during the quarter.
  • CAAS Capital Management sold 14,383 2seventy bio shares in Q2 2023, an estimated $147K.
  • CAAS Capital Management first reported a position in 2seventy bio in Q4 2021 and held it in 5 quarters.
  • CAAS Capital Management's 2seventy bio position peaked at $9.23M in Q2 2022.
  • 149 funds tracked by Wall St. Rank held 2seventy bio as of Q2 2023.

Based on CAAS Capital Management's 13F filing for Q2 2023, filed 14 Aug 2023.